University of SaskatchewaneCommons
  • Browse
    • All of eCommons
    • Communities & Collections
    • By Issue Date
    • Authors
    • Titles
    • Subjects
    • This Collection
    • By Issue Date
    • Authors
    • Titles
    • Subjects
  • My Account
    • Login
    • Register
        • Login
        View Item 
        • eCommons Home
        • College of Graduate and Postdoctoral Studies
        • Electronic Theses and Dissertations
        • View Item
        • eCommons Home
        • College of Graduate and Postdoctoral Studies
        • Electronic Theses and Dissertations
        • View Item
        JavaScript is disabled for your browser. Some features of this site may not work without it.

        Allergen Inhalation Challenge, Refractoriness, and the Effects of Ibuprofen

        Thumbnail
        View/Open
        NOMANI-THESIS-2016.pdf (1.727Mb)
        Date
        2016-06-09
        Author
        Nomani, Shawn Nomani
        Type
        Thesis
        Degree Level
        Masters
        Abstract
        Background: Bronchoprovocation challenges use direct and indirect acting stimuli to induce airflow obstruction. Indirect stimuli, either non-allergic/non-IgE mediated (e.g. exercise, mannitol) or allergic/IgE mediated (i.e. allergen inhalation model), trigger mast cells to release bronchoconstricting mediators (e.g. cysteinyl leukotrienes, histamine). Performing repeat challenges within a short timeframe (e.g. 3 hours) with non-allergic indirect stimuli results in a diminished refractory response to the second challenge. Cross refractoriness occurs between indirect stimuli. It follows that repeat bronchoprovocation with allergen might exhibit refractoriness that might be altered by ibuprofen. This study was designed to assess the response to a second allergen challenge performed 24 hours after an initial one to determine if the response is refractory. If refractoriness developed, the study aimed to determine whether a single dose of ibuprofen would alter the refractory response to the second allergen challenge. The study design also allowed for the assessment of the effect of ibuprofen on allergen challenge outcomes, including indices of airway inflammation. Methods: Thirteen mild atopic asthmatics were enrolled in a randomized, double-blind, placebo controlled, cross-over study. Ibuprofen (400mg) or placebo was administered one hour prior to the first of two allergen challenges performed 24 hours apart. Blood and sputum eosinophils, airway responsiveness to methacholine, and levels of fractional exhaled nitric oxide were assessed before and seven hours after each allergen challenge. All data were log transformed, and differences in geometric means were analyzed by paired t-tests. Results: After placebo, early asthmatic responses for the two challenges were not significantly different (p = 0.82). A single 400 mg dose of ibuprofen decreased both the early (p = 0.03; n = 12) and late asthmatic responses (p = 0.03; n = 3) Conclusion: Allergen challenges conducted 24 hours apart do not exhibit refractoriness. A single dose of ibuprofen inhibits early and late asthmatic responses to allergen bronchoprovocation. Ibuprofen should be withheld for at least 24 hours prior to investigations utilizing allergen bronchoprovocation.
        Degree
        Master of Science (M.Sc.)
        Department
        Physiology
        Program
        Physiology
        Supervisor
        Cockcroft, Donald; Davis, Beth
        Committee
        Lee, Paul; Campanucci, Veronica
        Copyright Date
        May 2016
        URI
        http://hdl.handle.net/10388/7280
        Subject
        Repeated
        Allergen Challenge
        Refractoriness
        Ibuprofen
        Collections
        • Electronic Theses and Dissertations
        • College of Graduate Studies & Research
        • University Library
        University of Saskatchewan

        © University of Saskatchewan
        Contact Us | Disclaimer | Privacy